Blue Note leukaemia DTx gets FDA breakthrough tag
pharmaphorum
JANUARY 11, 2022
According to Blue Note it is intended “to blunt the unique psychological stressors endured by this subset of patients with AML” It isn’t intended for AML patients treated as outpatients. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on.
Let's personalize your content